Ackrell Capital Cannabis Investment Report predicts federal legalization timeline

Ackrell Capital Cannabis Investment Report predicts federal legalization timeline The passage is a market forecast report without concrete allegations, specific transactions, or links to high‑profile officials. It offers no actionable investigative leads, merely speculative timelines for FDA approvals and legislative changes. Key insights: Predicts FDA will approve cannabis‑derived pharmaceuticals and adopt routine approval procedures.; Forecasts state adoption of medical and recreational cannabis laws.; Projects removal of cannabis from CSA schedules by 2027.